Gene · 6580
Papers3,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dietary polyphenols and their relationship to the modulation of non-communicable chronic diseases and epigenetic mechanisms: A mini-review. | Food Chem (Oxf) | 2023 | 36582744 | PubTator, text mining | PubMed |
| Pharmacogenomics-a New Frontier for Individualized Treatment of Parkinson's Disease. | Curr Neuropharmacol | 2023 | 36582064 | PubTator, text mining | PubMed |
| Metformin-'BRAINS & AIMS' pharmacological/prescribing principles of commonly prescribed (Top 100) drugs: Education and discussion. | Br J Clin Pharmacol | 2023 | 36575901 | PubTator, text mining | PubMed |
| Selective Inhibition of Organic Cation Transporter 1 by Benzoylpaeoniflorin Attenuates Hepatic Lipid Accumulation through AMPK Activation. | J Nat Prod | 2023 | 36563333 | PubTator, text mining | PubMed |
| Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis. | Am J Clin Dermatol | 2023 | 36538235 | PubTator, text mining | PubMed |
| Inhibitors of One or More Cellular Aurora Kinases Impair the Replication of Herpes Simplex Virus 1 and Other DNA and RNA Viruses with Diverse Genomes and Life Cycles. | Microbiol Spectr | 2023 | 36537798 | PubTator, text mining | PubMed |
| Implications of genetic variations, differential gene expression, and allele-specific expression on metformin response in drug-naïve type 2 diabetes. | J Endocrinol Invest | 2023 | 36528847 | PubTator, text mining | PubMed |
| Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response. | Gut Microbes | 2023 | 36519342 | PubTator, text mining | PubMed |
| Circulating selenoprotein P levels predict glucose-lowering and insulinotropic effects of metformin, but not alogliptin: A post-hoc analysis. | J Diabetes Investig | 2023 | 36479595 | PubTator, text mining | PubMed |
| Systematic characterization and biological functions of non-coding RNAs in glioblastoma. | Cell Prolif | 2023 | 36457281 | PubTator, text mining | PubMed |
| Real-world data for the renal safety of abemaciclib combined with bisphosphonate in HR+/HER2- advanced breast cancer. | Thorac Cancer | 2023 | 36351632 | PubTator, text mining | PubMed |
| Recapitulating the Pharmacological Interactions of Cetuximab with Sunitinib and Cisplatin in Head and Neck Carcinoma Cells in vitro. | Pharmacology | 2023 | 36273461 | PubTator, text mining | PubMed |
| Impact of cognition-related single nucleotide polymorphisms on brain imaging phenotype in Parkinson's disease. | Neural Regen Res | 2023 | 36255006 | PubTator, text mining | PubMed |
| Tumour, whole-blood, plasma and tissue concentrations of metformin in lung cancer patients. | Br J Clin Pharmacol | 2023 | 36164710 | PubTator, text mining | PubMed |
| SPK1/S1P axis confers gastrointestinal stromal tumors (GISTs) resistance of imatinib. | Gastric Cancer | 2023 | 35999321 | PubTator, text mining | PubMed |
| MicroRNA-204-5p: A pivotal tumor suppressor. | Cancer Med | 2023 | 35908280 | PubTator, text mining | PubMed |
| Personalizing Direct Oral Anticoagulant Therapy for a Diverse Population: Role of Race, Kidney Function, Drug Interactions, and Pharmacogenetics. | Clin Pharmacol Ther | 2023 | 35857814 | PubTator, text mining | PubMed |
| COVID-19: gastrointestinal and hepatobiliary manifestations. | Hum Pathol | 2023 | 35843340 | PubTator, text mining | PubMed |
| Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH). | Clin Pharmacol Ther | 2023 | 35429164 | PubTator, text mining | PubMed |
| Preclinical species gene expression database: Development and meta-analysis. | Front Genet | 2022 | 36733943 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6580/papers?page=21